Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19

Microbiology Spectrum(2023)10.1128/spectrum.04240-22Source: DataRank Database

mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19 is a research paper published in Microbiology Spectrum (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

gisaid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 1.52)OA: goldTopics (55)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Sherri L. Surman ORCID,Bart G. Jones,Robert E. Sealy,Trushar Jeevan,Christopher J.H. Davitt ORCID

Live enrichment

PubMed:36695597 PMC:PMC9927305 OpenAlex:https://openalex.org/W4317938606

HHS | National Institutes of Health

Grant: R01-AI139251

HHS | National Institutes of Health

Grant: U01-AI151810

NIAID NIH HHS

Grant: U01 AI151810

NIAID NIH HHS

Grant: R01 AI139251

National Institutes of Health

Grant: 5R01AI139251-02

IDENTIFICATION AND CHARACTERIZATION OF RNA STRUCTURES IN THE GENOME OF INFLUENZA VIRUS

National Institutes of Health

Grant: 3U01AI151810-03S1

Emerging infections: surveillance, epidemiology and pathogenesis

HHS | NIH | National Cancer Institute

GreenLight Bioscience

American Lebanese Syrian Associated Charities

FWCI

1.52

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

goldLicense: cc-by

journalhttps://journals.asm.org/doi/pdf/10.1128/spectrum.04240-22?download=true

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.04240-22?download=true

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.04240-22

journalhttps://doi.org/10.1128/spectrum.04240-22

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36695597

Fields of Study

SARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyAnimal Virus Infections Studies0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesmRNA VaccinesAnimalsAntibodies, ViralCricetinaeHumansMiceAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakVaccinationVirologyBetacoronavirusSars virusPathogenBiologyMedicineImmunologyOutbreakDiseaseInfectious disease (medical specialty)Internal medicineVaccinesmRNACoronavirusSars-cov-2COVID-19 VaccinesAntibodies, ViralMicrobiologyAntibodies630MiceCricetinaeMedicine and Health SciencesAnimalsHumansViralNeutralizingICTS (Institute of Clinical and Translational Sciences)COVID-19Antibodies, NeutralizingQR1-502Spike Glycoprotein, CoronavirusmRNA VaccinesResearch Article

Sustainable Development Goals

SDG 0: Good health and well-being

mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19

FAIR Checklist

Authors (12)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)